Anemia
📧 Sign up to get email alerts when something new happens for Anemia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-08-21EMA Suspended: Oxbryta (voxelotor) — Pfizer Europe MA EEIG
The EMA suspended Oxbryta (voxelotor) for treating sickle cell disease-related anemia.
-
CLINICAL_TRIALS trial_result · 2026-08-17Clinical Trial Results: Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor
A completed clinical trial evaluating reticulocyte hemoglobin content (RET-he) in the management of functional anemia in adults with solid t…
-
EMA approval · 2026-08-04EMA Authorised: Silapo (epoetin zeta) — Stada Arzneimittel AG
The EMA authorises Silapo (epoetin zeta) by Stada Arzneimittel AG for treating anemia associated with cancer, chronic kidney failure, and bl…
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Update: Liberal Transfusion Strategy in Elderly Patients [Phase 3]
Phase 3 trial update on liberal transfusion strategy in elderly patients completed.
-
EMA approval · 2026-07-20EMA Authorised: Retacrit (epoetin zeta) — Pfizer Europe MA EEIG
Authorised status for Retacrit (epoetin zeta) by EMA for use in anemia-related indications, including kidney failure, cancer-related anemia,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Update: Liberal Transfusion Strategy in Elderly Patients [Phase 3]
A Phase 3 clinical trial evaluating liberal transfusion strategy in elderly patients has completed.
-
EMA approval · 2026-07-03EMA Authorised: NeoRecormon (epoetin beta) — Roche Registration GmbH
NeoRecormon (epoetin beta) has been authorised by the EMA for related indications in chronic kidney failure, anemia, cancer, and autologous …
-
EMA approval · 2026-04-28EMA Authorised: Xromi (hydroxycarbamide) — Lipomed GmbH
Xromi (hydroxycarbamide) has been authorised in the EU for use in anemia and sickle cell disease.
-
EMA approval · 2026-04-28EMA Authorised: Siklos (hydroxycarbamide) — Theravia
Authorization of Siklos (hydroxycarbamide) in the European market for anemia and sickle cell indications.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Vitamin B12 Supplementation During Pregnancy on Cognitive Development [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating vitamin B12 supplementation during pregnancy and its effect on cognitive development.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly [Phase 1]
Phase 1 clinical trial evaluating an oral nutritional supplement and its effects on nutritional status in the elderly. The study also examin…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of DISC-0974-201 in Participants With IBD and Anemia [Phase 2]
A Phase 2 study evaluating DISC-0974-201 in inflammatory bowel disease and anemia is currently recruiting. The sponsor is Disc Medicine, Inc…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918. [Phase 1]
This document announces an ongoing Phase 1 clinical trial evaluating APG-5918 for anemia, focusing on safety, pharmacokinetics, and prelimin…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of the combination of vorinostat and azacitidine in patients with myelodysplastic syndr…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy [NA]
A long-term outcomes sub-study of preoperative combined iron therapy for iron-deficiency anemia in patients undergoing cardiac surgery; the …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Anemia Therapy in Patients With Infective Endocarditis [Phase 4]
Phase 4 clinical trial evaluating anemia therapy in patients with Infective Endocarditis. The study is not yet recruiting.
-
EMA approval · 2026-04-10EMA Authorised: Evrenzo (roxadustat) — Astellas Pharma Europe B.V.
EMA authorised Evrenzo (roxadustat) for the treatment of anemia associated with chronic kidney disease.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Mechanisms Accounting for Unexplained Anemia in the Elderly [Phase 1]
This clinical trial update reports a Phase 1 study funded by the National Institute on Aging that aims to understand mechanisms underlying u…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes [Phase 2]
A Phase 2 clinical trial is evaluating dapagliflozin for treating anemia in patients with lower-risk myelodysplastic syndromes, currently no…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya [NA]
This clinical trial update examines the effects of the levonorgestrel-releasing intrauterine system on hemoglobin and serum ferritin in anem…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Reducing Anemia Among Preconception Women in Nepal Through a Group Norm and Micronutrient Supplementation Intervention [NA]
This document reports an ongoing clinical trial in Nepal aiming to reduce anemia among preconception women using a group norms approach comb…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Registry Platform Myelofibrosis and Anemia
A ClinicalTrials.gov registry entry for a recruiting trial by iOMEDICO AG focused on myelofibrosis and anemia. It lists several MF-related c…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease [NA]
A clinical trial examining screening for renal complications in children and young adults with major sickle cell disease has completed.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania [NA]
This clinical trial update describes a study in Tanzania evaluating multiple micronutrient supplementation with a digital layering approach …
-
EMA approval · 2026-03-24EMA Authorised: Vafseo (vadadustat) — Medice Arzneimittel Pütter GmbH & Co. KG
The EMA authorised vadadustat (brand Vafseo) for the treatment of anemia associated with chronic kidney disease in the EU.